Multicenter study on acute type A aortic dissection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Nordic Consortium for Acute Type A Aortic Dissection-2 (NORCAAD-2) is a collaborative observational study involving multiple centers across the Nordic countries and the Netherlands. It aims to gather comprehensive data on patients with acute type A aortic dissection, focusing on preoperative characteristics, risk factors, surgical procedures, postoperative outcomes, and mortality rates over both short and long terms. By analyzing a large cohort of patients, the study seeks to enhance understanding of this critical vascular emergency and identify factors influencing outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Acute (within 14 days of onset) type A aortic dissection or similar acute aortic syndrome

Exclusion Criteria:

* Age \<18 years at onset

Where it's running

• Karolinska Institute
  Stockholm, Sweden Recruiting

Study contacts

• Principal investigator: Christian Olsson, MD, PhD — Karolinska Institutet
• Study coordinator: Christian Olsson, MD, PhD
• Email: christian.olsson@ki.se
• Phone: +46812370000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pregnancy-Related Aortic Dissection in China

  This study looks at cases of aortic dissection that occur during pregnancy or shortly after, to understand outcomes for mothers and babies.

  Recruiting at 4 sites DeltaHealth Hospital · Shanghai · Shanghai, Shanghai Municipality and 3 other locations · NCT07672210

• Ketorolac to improve outcomes and prognosis in Stanford Type A aortic dissection

  This trial will test whether giving ketorolac around emergency surgery helps adults (18–65) with Stanford Type A aortic dissection recover better and have fewer complications over 90 days.

  Recruiting Phase 3 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT06968806

• WeFlow-EndoPatch for Distal Aortic Tear Repair in Chronic Dissection

  This study tests whether the WeFlow-EndoPatch Aortic Endovascular Patch can safely and effectively seal distal tears in chronic aortic dissection compared with standard treatment.

  Recruiting Hangzhou Endonom Medtech Co., Ltd. · Beijing, Beijing Municipality · NCT06945809

• Aortic arch single-branch covered stent graft for treating aortic dissection

  This trial tests a single-branch covered stent graft in adults with Stanford Type B aortic dissection who need revascularization of the left subclavian artery.

  Recruiting Lifetech Scientific (Shenzhen) Co., Ltd. · Changsha · NCT06915545

• Shape‑memory polymer to seal the false lumen and prevent aortic enlargement

  This trial will try a shape‑memory polymer implant to seal the false lumen and stop aortic growth in adults with type B dissection or treated type A dissection who need false lumen repair.

  Recruiting at 2 sites Shape Memory Medical, Inc. · Auckland and 1 other locations · NCT06550986

• Using sivelestat to protect lung function after heart surgery

  This study is testing if giving sivelestat to patients having emergency heart surgery can help protect their lungs and improve recovery by reducing serious complications.

  Recruiting at 2 sites Nanjing Medical University · Beijing and 1 other locations · NCT06195267

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.